Daniel Freeman Selected Research

Daniel Freeman Research Topics

Disease

32	Psychotic Disorders (Schizoaffective Disorder) 12/2023 - 08/2006
15	Paranoid Disorders (Paranoia) 12/2022 - 05/2005
11	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2023 - 07/2013
8	Neoplasms (Cancer) 10/2023 - 03/2010
6	COVID-19 10/2023 - 01/2021
6	Hallucinations (Hallucination) 10/2017 - 07/2013
4	Schizophrenia (Dementia Praecox) 01/2022 - 07/2014
3	Mental Disorders (Mental Disorder) 01/2018 - 06/2005
3	Sarcoma (Soft Tissue Sarcoma) 08/2013 - 06/2011
2	Infections 05/2022 - 10/2021
2	Weight Gain 01/2022 - 01/2020
2	Sleep Wake Disorders 01/2021 - 05/2018
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 12/2016
2	Wounds and Injuries (Trauma) 12/2016 - 07/2008
1	Disease Progression 10/2023
1	Adenocarcinoma 01/2023
1	Specific Phobia 01/2023
1	Cholangiocarcinoma 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Phobic Disorders (Phobia) 01/2023
1	Thrombosis (Thrombus) 12/2022
1	Agoraphobia 12/2022
1	Hematologic Neoplasms (Hematological Malignancy) 12/2022
1	Multiple Sclerosis 05/2022
1	Systemic Scleroderma (Systemic Sclerosis) 07/2021
1	Sleepiness 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Acrophobia 01/2018
1	Hyperthyroidism 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2015
1	Anhedonia 07/2014
1	Hypertrophy 09/2008
1	Fibrosis (Cirrhosis) 09/2008
1	Pulmonary Edema 09/2008
1	Hemosiderosis 09/2008
1	Hemorrhage 09/2008
1	Atherosclerosis 12/2005
1	Cataract (Cataracts) 12/2005
1	Lactic Acidosis 12/2005
1	Hyperuricemia 12/2005

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 10/2023 - 01/2021
6	COVID-19 VaccinesIBA 10/2023 - 07/2021
6	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 07/2019
3	Polytetrafluoroethylene (Teflon)FDA Link 07/2019 - 03/2015
3	Illicit Drugs (Recreational Drugs)IBA 09/2015 - 07/2008
3	src-Family KinasesIBA 08/2013 - 06/2011
3	Adenosine Triphosphate (ATP)IBA 08/2013 - 06/2011
2	chemotactic factor inactivatorIBA 01/2021 - 04/2010
2	SolutionsIBA 11/2018 - 07/2014
2	Dihydrotachysterol (AT 10)IBA 10/2017 - 05/2015
2	Dronabinol (THC)FDA LinkGeneric 11/2015 - 03/2015
2	Protein Kinases (Protein Kinase)IBA 08/2013 - 08/2011
2	N 30IBA 06/2005 - 05/2005
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	CannabidiolIBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2017
1	ParaffinIBA 01/2017
1	histidine-rich proteinsIBA 01/2017
1	Neuregulin-1 (Neuregulin 1)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	patritumabIBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	A-factor (Streptomyces)IBA 07/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 09/2015
1	Cocaine (Cocaine HCl)IBA 09/2015
1	GoldIBA 08/2013
1	tau-tubulin kinaseIBA 08/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2013
1	Glycogen Synthase Kinase 3IBA 08/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2011
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2011
1	Ethylene Glycol (Monoethylene Glycol)IBA 08/2011
1	Casein Kinase II (Casein Kinase 2)IBA 08/2011
1	isoleucyl-tyrosineIBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 06/2011
1	Peptides (Polypeptides)IBA 06/2011
1	IronIBA 09/2008
1	Dopamine (Intropin)FDA LinkGeneric 07/2008
1	FructoseIBA 12/2005

Therapy/Procedure

39	Therapeutics 12/2023 - 08/2006
2	Aftercare (After-Treatment) 01/2022 - 12/2016
2	Secondary Prevention 06/2008 - 10/2007
1	Relaxation Therapy (Relaxation Technique) 11/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Injections 01/2023
1	Immunotherapy 02/2019
1	Intravenous Administration 03/2015